Inari Medical, Inc. (NARI) |
| 79.97 0 (0%) 02-18 16:00 |
| Open: | 79.96 |
| High: | 79.97 |
| Low: | 79.96 |
| Volume: | 2,356,692 |
| Market Cap: | 4,683(M) |
| PE Ratio: | -59.24 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 12.89 |
| Resistance 1: | 11.04 |
| Pivot price: | 10.49 |
| Support 1: | 10.48 |
| Support 2: | 10.13 |
| 52w High: | 79.99 |
| 52w Low: | 36.73 |
Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
| EPS | 0.810 |
| Book Value | 13.250 |
| PEG Ratio | 1.33 |
| Gross Profit | 1.419 |
| Profit Margin (%) | 47.29 |
| Operating Margin (%) | 41.43 |
| Return on Assets (ttm) | 1.4 |
| Return on Equity (ttm) | 6.9 |
Wed, 19 Feb 2025
Inari Medical, Inc. (NARI): the Best Performing Healthcare Stock So Far in 2025 - Yahoo Finance
Wed, 05 Feb 2025
Reasons to Retain Inari Medical Stock in Your Portfolio for Now - Yahoo Finance
Tue, 28 Jan 2025
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ENFN, RDW, NARI, VCSA on Behalf of Shareholders - Finansavisen
Fri, 10 Jan 2025
Stryker enters peripheral vascular segment with Inari Medical acquisition - MedTech Intelligence
Mon, 06 Jan 2025
Stryker plans $4.9 billion offer to acquire California medical device firm - Crain's Grand Rapids Business
Thu, 20 Jun 2024
NARI Investors Have Opportunity to Lead Inari Medical, Inc. Secu - GuruFocus
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |